|
시장보고서
상품코드
2126535
의료용 일회용품 : 시장 인사이트, 경쟁 구도 및 시장 예측(2034년)Medical Disposable Products - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
개요 :
- 의료용 일회용 제품 시장은 2025년에 5,045억 달러로 추산되며, 2034년까지 9,167억 달러에 달할 것으로 예측됩니다. 이러한 성장의 배경에는 외과수술 및 진단 시술 건수의 증가, 모든 의료 현장에서의 감염 관리 프로토콜 강화, 그리고 전 세계 병원 및 외래 수술 시설의 인프라 확충이 있습니다.
- 전 세계 의료용 일회용 제품 시장은 2026-2034년까지의 예측 기간 중 연평균 성장률(CAGR) 6.65%로 성장하고 있습니다.
- 제품 유형별로는 2025년에 일회용 장갑 부문이 28%의 점유율을 차지하며 의료용 일회용 제품 시장을 주도했습니다.
- 소재별로는 2025년에 플라스틱 부문이 46%의 점유율을 차지하며 의료용 일회용 제품 시장을 주도했습니다.
- 멸균 상태별로는 2025년에 ‘멸균 처리된’ 부문이 의료용 일회용 제품 시장에서 68%의 점유율을 차지하며 시장을 주도했습니다.
- 용도별로는 2025년에 감염 관리 부문이 의료용 일회용 제품 시장에서 33%의 점유율을 차지하며 시장을 선도했습니다.
- 최종사용자별로는 2025년 병원 부문이 의료용 일회용 제품 시장에서 58%의 점유율을 차지하며 시장을 독점했습니다.
- 북미는 2025년에 40%의 점유율로 전 세계 의료용 일회용 제품 시장의 매출을 주도하며, 전 세계에서 가장 높은 지역별 시장 점유율을 기록했습니다.
의료용 일회용 제품이란 주사기,바늘, 장갑, 수액 세트부터 수술용 드레이프, 상처 피복재, 요도 카테터에 이르기까지 한 번 사용하고 폐기되도록 설계된 일회용 의료기기 또는 소모품으로, 교차 오염 및 병원내 감염(HAI)의 위험을 최소화하는 것을 목적으로 합니다. 재사용 가능한 기구는 고비용의 멸균 주기가 필요하고 감염 위험이 남아 있을 뿐만 아니라, 현대적인 외과수술, 진단 및 중환자 치료의 처치량에 항상 대응할 수 있는 것은 아니기 때문에 전 세계의 병원, 외래 수술 센터,진단 검사실에서는 일상적인 치료나 응급 치료시 일회용 제품에 크게 의존하고 있습니다. 이러한 제품은 약물 투여 및 정맥 주사, 채혈 및 수혈, 호흡 보호, 상처 관리, 외과수술, 비뇨기 관리 등 다양한 분야에 걸쳐 있습니다. 시장은 제품 유형별로 일회용 주사기 및 바늘, 정맥내 투여·수액 제품, 채혈·수혈 제품, 일회용 장갑, 수술용 마스크 및 호흡기용 일회용 제품, 수술용 드레이프 및 가운,상처 관리 및 드레싱 제품, 요로·비뇨기용 일회용 제품으로 분류됩니다. 또한 소재별로는 플라스틱, 고무 및 라텍스, 부직포, 종이 및 판지, 유리로 분류됩니다. 아울러 무균 상태별로는 멸균 처리된 제품 및 비멸균 제품으로, 용도별로는 외과수술, 감염 관리, 약물 투여 및 수액, 상처 관리, 진단 및 임상 검사, 채혈 및 수혈, 호흡 관리로 분류됩니다. 또한 최종사용자별로는 병원이 주를 이룹니다. 외과수술 및 진단 건수의 증가, 감염 관리 기준의 엄격화, 만성질환의 부담이 커지는 고령화 사회, 그리고 외래·통원 의료 체계의 지속적인 확충에 힘입어 의료용 일회용 제품은 안전하고 효율적인 환자 관리를 지원하는 기반 인프라로 자리 잡고 있습니다.
의료용 일회용 제품 시장의 주요 성장 촉진요인
- 전 세계 수술 및 진단 검사 건수의 증가에 따라 일회용 주사기, 수술용 드레이프, 수술용 가운, 시술 키트의 소비량이 직접적으로 증가하고 있으며, 병원 및 외래 수술 센터에서는 해마다 더 많은 환자를 처리하고 있습니다.
- COVID-19 팬데믹으로 인해 감염 관리 기준이 강화됨에 따라 병원, 진료소, 검사실 전반에 걸쳐 일회용 장갑, 마스크, 호흡기용 일회용 제품에 대한 기본적인 수요가 지속적으로 증가하고 있습니다.
- 전 세계에서 만성질환 및 감염병의 부담이 증가함에 따라 특히 고령화가 진행되고 있는 인구층에서 정맥내 투여 및 수액 제품, 채혈 및 수혈용 소모품, 상처 관리 및 드레싱 제품에 대한 수요가 확대되고 있습니다.
- 외래 수술 센터 및 외래 진료 시설의 급속한 확대로 인해 일회용 제품의 최종사용자층은 기존의 병원 인프라의 범위를 넘어 확대되고 있습니다.
- FDA와 EMA를 비롯한 규제 당국은 외과수술, 약물 투여 및 혈액 취급 용도의 일회용·멸균 제품에 대한 요건을 지속적으로 강화하고 있으며, 규제를 준수하는 일회용 제품에 대한 수요를 지원하고 있습니다.
- BD와 Molnlycke Health Care를 비롯한 주요 제조업체들은 주사기, 바늘, 상처 관리 제품 등의 국내 생산 능력에 수억 달러를 투자하며, 지역별로 분산된 신뢰할 수 있는 공급 체계를 강화하고 있습니다.
- 수술 건수의 증가, 감염 관리 기준, 만성질환의 부담, 그리고 외래 진료의 확대가 맞물려 2034년까지 시장은 꾸준한 성장을 유지할 것으로 예상됩니다.
의료용 일회용 제품 시장의 성장에 기여하는 요인
시장 촉진요인
수술 및 진단 시술 건수의 증가
의료용 일회용 제품 시장의 가장 일관된 촉진요인은 병원 및 외래 수술 센터에서 전 세계에서 꾸준히 증가하는 외과수술 및 진단 시술 건수입니다. 일상적인 외래 시술부터 복잡한 입원 수술에 이르기까지 각 시술에서는 교차 오염의 위험을 배제하기 위해 일회용으로 설계된 일회용 주사기, 바늘, 드레이프, 가운 및 시술 키트가 사용됩니다. 인구 고령화가 진행되고 심혈관 질환, 당뇨병, 암 등 만성질환의 유병률이 높아짐에 따라 진단 검사, 최소 침습 시술, 외과적 개입의 빈도도 마찬가지로 증가하고 있습니다. 외래 수술 센터는 기존에 병원에서 이루어지던 선택적 수술의 비중을 점점 더 흡수하고 있으며, 새로운 의료 제공 거점이 하나 늘어날 때마다 일회용 제품에 대한 수요가 단계적으로 증가하고 있습니다. 수술 및 진단 현장에서 무균 상태의 유지와 일회용 사용 준수는 절대적인 조건이므로, 이러한 수술 건수의 증가는 2034년에 이르기까지 일회용 제품의 소비량 증가로 직접적이고 지속적으로 이어질 것입니다.
감염 관리 기준 강화
COVID-19 팬데믹은 의료 분야 전반에 걸쳐 감염 예방에 대한 기본적인 기대치를 영구적으로 재정의했습니다. 이처럼 높아진 기준은 일회용 장갑, 수술용 마스크, 호흡기용 일회용 제품에 대한 수요를 지속적으로 견인하고 있습니다. 병원, 진료소, 검사실 및 장기 요양 시설에서는 팬데믹 이전과 비교하여 장갑 교체 빈도 증가, 특정 환경에서의 보편적인 마스크 착용 프로토콜, 그리고 더욱 엄격한 개인 보호 장비(PPE) 사용이 제도화되었습니다. 규제 당국과 인증 기관은 병원 인증 및 보험 환급 조건으로 감염 관리 준수를 지속적으로 강화하고 있으며, 이로 인해 일회용 PPE 소비량은 역사적 수준보다 구조적으로 높은 수준을 유지하고 있습니다. 신흥 시장의 의료 시스템이 세계 표준에 부합하기 위해 감염 관리 인프라를 구축함에 따라 이러한 수요 요인은 지역적으로 확대될 것이며, 예측 기간 중 수요 성장이 지속될 것으로 예상됩니다.
시장 제약 요인
견고한 기초 수요가 있음에도 불구하고 의료용 일회용 제품 시장은 중대한 제약에 직면해 있습니다. 일회용 플라스틱 폐기물에 대한 환경적 우려가 높아짐에 따라 일부 관할 구역에서는 확대 생산자 책임(EPR) 수수료를 포함한 규제 당국의 엄격한 감시가 이루어지고 있으며, 이는 제조업체들이 무균성이나 비용을 저해하지 않으면서 생분해성 및 재활용 가능한 대체품을 개발하도록 압박하고 있습니다. 특히 장갑이나 주사기와 같은 상품화된 부문에서는 치열한 경쟁과 환급 압박이 이익률을 압박하고 있으며, 소규모 지역 제조업체보다 대규모의 저비용 생산자가 유리한 입장에 있습니다. 석유화학제품의 가격 변동 및 공급 차질로 인한 플라스틱, 니트릴, 라텍스 등의 원자재 가격 변동은 밸류체인 전반에 걸쳐 비용 불확실성을 초래하고 있습니다. 가격에 민감한 시장에서 저가의, 경우에 따라는 위조품이나 규격에 맞지 않는 일회용 제품이 범람하고 있는 것은 품질 및 환자 안전에 대한 우려를 야기하며, 규제를 준수하는 제조업체의 경쟁 환경을 복잡하게 만들고 있습니다. 복잡하고 국경을 초월한 규제 승인 및 멸균 검증 요건은 제품 개발 기간을 길게 만들고, 규정 준수 비용을 상승시키고 있습니다. 한편, 팬데믹 당시 장갑 및 개인보호장비(PPE) 부족에서 볼 수 있었던 것처럼, 간헐적인 공급망 혼란은 원자재 및 완제품 생산의 지역적 집중이 초래하는 위험을 여전히 드러내고 있습니다. 이러한 환경, 가격, 품질, 규제, 공급망에 대한 압박이 맞물리면서, 수술 건수 증가, 감염 방지 대책, 만성질환의 부담과 같은 근본적인 성장 요인이 여전히 견고함에도 불구하고 성장 속도가 둔화되고 있습니다.
자주 묻는 질문
목차
제1장 의료용 일회용품 시장 : 서론
제2장 의료용 일회용품 시장 : 개요
제3장 의료용 일회용품 시장 : 주요 요인 분석
제4장 AI, 지정학, 무역 및 경제의 동향
제5장 규제 분석
제6장 Porter's Five Forces 분석
제7장 의료용 일회용품 시장 : 평가
제8장 의료용 일회용품 시장 : 경쟁 구도
제9장 의료용 일회용품 시장 : 스타트업 자금조달 및 투자 동향
제10장 의료용 일회용품 시장 : 기업 개요 및 제품 개요
제11장 KOL의 견해
제12장 프로젝트 어프로치
제13장 DelveInsight 소개
제14장 면책사항 및 문의
KSA 26.09.14Medical Disposable Products Market Summary
Overview:
- The Medical Disposable Products market is estimated at USD 504.5 billion in 2025 and is projected to reach USD 916.7 billion by 2034. Growth is anchored in rising surgical and diagnostic procedure volumes, intensifying infection-control protocols across care settings, and expanding hospital and ambulatory surgical infrastructure worldwide.
- The global Medical Disposable Products market is growing at a CAGR of 6.65% during the forecast period from 2026 to 2034.
- By product type, the disposable gloves segment dominated the Medical Disposable Products market with a 28% share in 2025.
- By material, the plastic segment dominated the Medical Disposable Products market with a 46% share in 2025.
- By sterility, the sterile segment dominated the Medical Disposable Products market with a 68% share in 2025.
- By application, the infection control segment dominated the Medical Disposable Products market with a 33% share in 2025.
- By end-users, the hospitals segment dominated the Medical Disposable Products market with a 58% share in 2025.
- North America dominated the global Medical Disposable Products market revenue with a 40% share in 2025, representing the highest regional market share globally.
A medical disposable product is a single-use device or consumable, ranging from syringes, needles, gloves, and IV sets to surgical drapes, wound dressings, and urinary catheters, that is designed to be used once and discarded to minimize the risk of cross-contamination and hospital-acquired infections (HAIs). Because reusable instruments require costly sterilization cycles, carry residual infection risk, and cannot always keep pace with the volume of modern surgical, diagnostic, and critical-care procedures, hospitals, ambulatory surgical centers, and diagnostic laboratories worldwide rely heavily on disposable products for routine and high-acuity care. These products span drug delivery and infusion, blood collection and transfusion, respiratory protection, wound management, surgical procedures, and urological care. The market is organized by product type across disposable syringes and needles, IV and infusion products, blood collection and transfusion products, disposable gloves, surgical masks and respiratory disposables, surgical drapes and gowns, wound care and dressing products, and urinary and urological disposables; by material across plastic, rubber and latex, nonwoven materials, paper and paperboard, and glass; by sterility across sterile and non-sterile; by application across surgical procedures, infection control, drug delivery and infusion, wound management, diagnostic and laboratory testing, blood collection and transfusion, and respiratory care; and by end-users, led by hospitals. Driven by rising surgical and diagnostic volumes, heightened infection-control standards, an aging population with growing chronic disease burden, and continued expansion of outpatient and ambulatory care capacity, medical disposable products have become foundational infrastructure underpinning safe, efficient patient care delivery.
Medical Disposable Products Market Key Growth Drivers
- Rising global surgical and diagnostic procedure volumes are directly increasing consumption of disposable syringes, drapes, gowns, and procedure kits, with hospitals and ambulatory surgical centers processing higher patient throughput each year.
- Heightened infection-control standards following the COVID-19 pandemic have permanently elevated baseline demand for single-use gloves, masks, and respiratory disposables across hospitals, clinics, and diagnostic laboratories.
- The rising global burden of chronic and infectious disease is expanding demand for IV and infusion products, blood collection and transfusion consumables, and wound care and dressing products, particularly among aging populations.
- The rapid growth of ambulatory surgical centers and outpatient care settings is broadening the end-user base for disposable products beyond traditional hospital infrastructure.
- Regulatory bodies including the FDA and EMA continue to reinforce single-use, sterile-product requirements in surgical, drug-delivery, and blood-handling applications, sustaining demand for compliant disposables.
- Leading manufacturers, including BD and Molnlycke Health Care, are investing hundreds of millions of dollars in domestic manufacturing capacity for syringes, needles, and wound care products, reinforcing reliable, regionally distributed supply.
- The convergence of rising procedure volumes, infection-control standards, chronic disease burden, and outpatient care expansion is expected to sustain steady growth in the market through 2034.
Key Companies in Medical Disposable Products Market
The competitive landscape is led by the following active manufacturers:
- Becton, Dickinson and Company (BD)
- Cardinal Health
- Medline Industries, Inc.
- 3M Company
- Medtronic plc
- Baxter International Inc.
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Molnlycke Health Care AB
Factors Contributing to the Growth of the Medical Disposable Products Market
Market Drivers
Rising Surgical and Diagnostic Procedure Volumes
The most consistent driver of the Medical Disposable Products market is the steady global rise in surgical and diagnostic procedure volumes across hospitals and ambulatory surgical centers. Each procedure, from routine outpatient interventions to complex inpatient surgeries, consumes disposable syringes, needles, drapes, gowns, and procedure kits designed for single use to eliminate cross-contamination risk. As populations age and the prevalence of chronic conditions such as cardiovascular disease, diabetes, and cancer increases, the frequency of diagnostic testing, minimally invasive procedures, and surgical interventions rises in parallel. Ambulatory surgical centers are absorbing a growing share of elective procedures previously performed in hospitals, and each new site of care represents incremental disposable-product demand. Because sterility and single-use compliance are non-negotiable in surgical and diagnostic settings, this procedural growth translates directly and durably into rising disposable-product consumption through 2034.
Heightened Infection-Control Standards
The COVID-19 pandemic permanently reset baseline expectations for infection prevention across healthcare, and this elevated standard continues to drive demand for disposable gloves, surgical masks, and respiratory disposables. Hospitals, clinics, diagnostic laboratories, and long-term care facilities have institutionalized higher glove-change frequency, universal masking protocols in select settings, and stricter personal protective equipment (PPE) usage than in the pre-pandemic era. Regulatory and accreditation bodies continue to reinforce infection-control compliance as a condition of hospital accreditation and reimbursement, keeping single-use PPE consumption structurally higher than historical norms. As healthcare systems in emerging markets upgrade infection-control infrastructure to align with global standards, this driver is expected to broaden geographically and sustain demand growth across the forecast period.
Market Restraints
Despite strong underlying demand, the Medical Disposable Products market faces material constraints. Mounting environmental concern over single-use plastic waste is drawing regulatory scrutiny, including extended producer responsibility (EPR) fees in several jurisdictions, and is pressuring manufacturers to develop biodegradable and recyclable alternatives without compromising sterility or cost. Intense price competition and reimbursement pressure, particularly in commoditized categories such as gloves and syringes, compress margins and favor large-scale, low-cost producers over smaller regional players. Raw material price volatility in plastics, nitrile, and latex, driven by petrochemical price swings and supply disruptions, creates cost unpredictability across the value chain. The proliferation of low-cost, and in some cases counterfeit or substandard, disposable products in price-sensitive markets raises quality and patient-safety concerns and complicates competitive dynamics for compliant manufacturers. Complex, cross-border regulatory approval and sterilization-validation requirements lengthen product development timelines and raise compliance costs, while episodic supply chain disruptions, as seen during the pandemic-era glove and PPE shortages, continue to expose the risks of geographic concentration in raw material and finished-goods production. Together, these environmental, pricing, quality, regulatory, and supply chain pressures temper the pace of growth, even as the underlying drivers of procedure volume, infection control, and chronic disease burden remain firmly intact.
Medical Disposable Products Market Segment Analysis
The medical disposable products market by product type (disposable syringes & needles, iv & infusion products, blood collection & transfusion products, disposable gloves, surgical masks & respiratory disposables, surgical drapes & gowns, wound care & dressing products, urinary & urological disposables, and others), material (plastic, rubber & latex, nonwoven materials, paper & paperboard, glass, and others), sterility (sterile and non-sterile), application (surgical procedures, infection control, drug delivery & infusion, wound management, diagnostic & laboratory testing, blood collection & transfusion, respiratory care, others), end-users (hospitals, ambulatory surgical centers, clinics & physician offices, diagnostic & research laboratories, and others), and geography (North America, Europe, Asia-Pacific, and Rest of World).
By Product Type
Dominant Subsegment: Disposable Gloves.
The disposable gloves segment accounted for 28% of the Medical Disposable Products market in 2025. Disposable gloves are the leading product type because they are used at the highest frequency of any disposable category, with hospital and clinical staff changing gloves for nearly every patient interaction across surgical, diagnostic, and routine care settings. Elevated post-pandemic infection-control protocols, combined with strict regulatory requirements around barrier protection in surgical and examination settings, sustain exceptionally high, recurring consumption. Nitrile gloves continue to gain share over natural rubber latex amid allergy concerns and supply diversification, while manufacturers expand domestic production capacity to reduce reliance on concentrated Southeast Asian supply. While disposable syringes and needles and wound care and dressing products post strong growth on the back of rising injectable therapy volumes and chronic wound prevalence, the sheer frequency and universality of glove usage across every care setting secure the segment's leadership across the forecast period.
By Material
Dominant Subsegment: Plastic.
The plastic segment accounted for 46% of the Medical Disposable Products market in 2025. Plastic is the leading material because it underpins the vast majority of disposable syringes, IV and infusion sets, urinary catheters, and packaging components, offering a favorable balance of cost, moldability, chemical inertness, and compatibility with sterilization processes such as ethylene oxide and gamma irradiation. Polypropylene and polyvinyl chloride remain the workhorse polymers for tubing, syringe barrels, and fluid-contact components across nearly every disposable product category. Nonwoven materials are growing quickly on the back of surgical drape, gown, and mask demand, and rubber and latex remain essential for gloves, but the breadth of plastic's application across the widest range of disposable product categories secures its leadership across the forecast period, even as manufacturers face growing pressure to develop bio-based and recyclable plastic alternatives.
Medical Disposable Products Market Region Analysis
Dominant Region: North America
North America accounted for 40% of the global Medical Disposable Products market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced, well-funded healthcare infrastructure, high per-capita healthcare spending, a dense concentration of hospitals and ambulatory surgical centers, and a strong regulatory framework anchored by the FDA. The United States hosts the largest concentration of leading manufacturers and distributors, including BD, Cardinal Health, Medline, and 3M, and continued domestic manufacturing investment, including BD's multi-billion-dollar U.S. capacity expansion, reinforces regional supply resilience. High surgical and diagnostic procedure volumes, an aging population with rising chronic disease burden, and stringent infection-control standards across hospitals and clinics sustain substantial disposable-product demand. Strong reimbursement frameworks and continued build-out of ambulatory surgical capacity anchor the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Medical Disposable Products market. The region's elevated CAGR is driven by rapid expansion of hospital and diagnostic infrastructure, rising healthcare expenditure, and growing surgical and procedural volumes across China, Japan, India, South Korea, and Australia. China continues to expand hospital bed capacity and domestic disposable-product manufacturing, India benefits from low-cost production and growing insurance penetration that is expanding access to surgical and diagnostic care, and Japan's aging population is driving sustained demand for wound care, infusion, and urological disposables. Government healthcare investment, expanding medical insurance coverage, and rising local and export manufacturing of gloves, syringes, and PPE position Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 40% of the global Medical Disposable Products market revenue in 2025. The United States dominates on the strength of its advanced hospital and ambulatory surgical infrastructure, high healthcare spending, and concentration of leading manufacturers, while continued domestic capacity investment by BD, Molnlycke, and other major players reinforces the region's supply resilience and leadership.
Europe
Europe is a large and advanced regional market, supported by established EMA regulatory frameworks, strong public healthcare systems, and growing wound care and infusion manufacturing capacity. Investment activity such as Molnlycke's expanded manufacturing footprint across Finland and the United Kingdom, and B. Braun's continued growth in eco-friendly syringe and infusion production, reinforce the region's role in supplying both hospital and outpatient care across Germany, France, the United Kingdom, Italy, and Spain.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by rising healthcare investment, expanding hospital and diagnostic infrastructure, and growing surgical and procedural volumes across China, Japan, India, South Korea, and Australia. China's expanding domestic manufacturing base, Molnlycke's new wound care site in Changshu, India's low-cost production and rising insurance penetration, and Japan's aging-population-driven demand for infusion and urological disposables are accelerating regional growth.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and healthcare infrastructure, rising demand for basic surgical and infection-control supplies, and efforts to align local regulatory frameworks with global GMP and sterility standards are gradually broadening access, while growing local manufacturing and international distribution partnerships support the build-out of regional supply capacity.
Medical Disposable Products Market Competitive Landscape
The Medical Disposable Products market is classified as Fragmented. A group of large, diversified manufacturers and distributors with global scale and broad product portfolios, including Becton, Dickinson and Company, Cardinal Health, Medline Industries, and 3M Company, anchor the top tier, while specialized and category-focused players such as Baxter International, B. Braun Melsungen, Terumo Corporation, Nipro Corporation, and Molnlycke Health Care compete through deep expertise in specific product categories such as infusion therapy, syringes and needles, and advanced wound care, increasing competition across individual product segments.
The competitive landscape can be evaluated across the following dimensions:
- Market concentration: Fragmented, with large diversified manufacturers and distributors leading and a broad field of category-specialized players competing on product depth and regional reach.
- Leading players: Becton, Dickinson and Company, Cardinal Health, Medline Industries, and 3M Company anchor the top tier through manufacturing scale and broad product portfolios.
- Geographic reach: Leaders operate global, regionally distributed manufacturing and distribution networks; Medline offers approximately 190,000 med-surg products across its Front Line Care, Surgical Solutions, and Laboratory and Diagnostics categories.
- Product portfolio strength: Top players offer end-to-end portfolios spanning syringes and needles, infusion products, gloves, respiratory disposables, drapes and gowns, wound care, and urological disposables.
- Manufacturing capacity: Ownership of domestic and regionally distributed manufacturing capacity, including BD's committed USD 2.5 billion U.S. manufacturing investment, is a decisive competitive advantage.
- Strategic partnerships and acquisitions: Active category consolidation, including Cardinal Health's acquisition of Advanced Diabetes Supply Group and Molnlycke's agreement to acquire wound-cleansing manufacturer P.G.F. Industry Solutions, extends category depth.
- Innovation focus: Advanced wound care technologies, low-dead-space and safety-engineered syringes, smart and connected disposables, and sustainable, low-waste, and biodegradable materials.
Medical Disposable Products Market Recent Developmental Activities
In April 2026, BD (Becton, Dickinson and Company) launched its AI-enabled Pyxis Pro Dispensing Solution and Incada Connected Care Platform in the European market, extending automated medication management and connected-care capabilities beyond the United States. Strategic significance: Expands BD's connected-care and medication-management footprint in Europe.
In February 2026, BD (Becton, Dickinson and Company) launched the BD Vacutainer Urine Complete Cup Kit, a three-tube collection system designed to expand testing capabilities and reduce repeat specimen collection. Strategic significance: Strengthens BD's diagnostic and specimen-collection disposables portfolio.
In January 2026, BD (Becton, Dickinson and Company) announced a USD 110 million investment to expand BD Neopak glass prefillable syringe and cannula production at its Columbus, Nebraska facility, part of a broader commitment exceeding USD 2.5 billion in U.S. manufacturing upgrades over five years. Strategic significance: Reinforces domestic prefillable syringe supply resilience for biologic and injectable drug delivery.
Medical Disposable Products Market Segmentation
Medical Disposable Products Market by Product Type
- Disposable Syringes & Needles
- IV & Infusion Products
- Blood Collection & Transfusion Products
- Disposable Gloves
- Surgical Masks & Respiratory Disposables
- Surgical Drapes & Gowns
- Wound Care & Dressing Products
- Urinary & Urological Disposables
- Others
Medical Disposable Products Market by Material
- Plastic
- Rubber & Latex
- Nonwoven Materials
- Paper & Paperboard
- Glass
- Others
Medical Disposable Products Market by Sterility
- Sterile
- Non-Sterile
Medical Disposable Products Market by Application
- Surgical Procedures
- Infection Control
- Drug Delivery & Infusion
- Wound Management
- Diagnostic & Laboratory Testing
- Blood Collection & Transfusion
- Respiratory Care
- Others
Medical Disposable Products Market by End-Users
- Hospitals
- Ambulatory Surgical Centers
- Clinics & Physician Offices
- Diagnostic & Research Laboratories
- Others
Medical Disposable Products Market by Geography
- North America Medical Disposable Products Market
- United States Medical Disposable Products Market Size in USD million (2023-2034)
- Canada Medical Disposable Products Market Size in USD million (2023-2034)
- Mexico Medical Disposable Products Market Size in USD million (2023-2034)
- Europe Medical Disposable Products Market
- Germany Medical Disposable Products Market Size in USD million (2023-2034)
- United Kingdom Medical Disposable Products Market Size in USD million (2023-2034)
- France Medical Disposable Products Market Size in USD million (2023-2034)
- Italy Medical Disposable Products Market Size in USD million (2023-2034)
- Spain Medical Disposable Products Market Size in USD million (2023-2034)
- Rest of Europe Medical Disposable Products Market Size in USD million (2023-2034)
- Asia-Pacific Medical Disposable Products Market
- China Medical Disposable Products Market Size in USD million (2023-2034)
- Japan Medical Disposable Products Market Size in USD million (2023-2034)
- India Medical Disposable Products Market Size in USD million (2023-2034)
- Australia Medical Disposable Products Market Size in USD million (2023-2034)
- South Korea Medical Disposable Products Market Size in USD million (2023-2034)
- Rest of Asia-Pacific Medical Disposable Products Market Size in USD million (2023-2034)
- Rest of the World (RoW) Medical Disposable Products Market
- Middle East Medical Disposable Products Market Size in USD million (2023-2034)
- Africa Medical Disposable Products Market Size in USD million (2023-2034)
- South America Medical Disposable Products Market Size in USD million (2023-2034)
Key Takeaways from the Medical Disposable Products Market Report Study
- Market size analysis for the current Medical Disposable Products market size (2025), and market forecast for 9 years (2026 to 2034).
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
- Key companies dominating the global Medical Disposable Products market.
- Various opportunities available for competitors in the Medical Disposable Products market space.
- What are the top-performing segments in 2025? How will these segments perform in 2034?
- Which are the top-performing regions and countries in the current Medical Disposable Products market scenario?
- Which are the regions and countries where companies should concentrate their opportunities for Medical Disposable Products market growth in the future?
Target audience who can benefit from this Medical Disposable Products market report study
- Medical Disposable Products product providers
- Research organizations and consulting companies
- Medical Disposable Products -related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in Medical Disposable Products
- Various end-users who want to know more about the Medical Disposable Products market and the latest technological developments in the Medical Disposable Products market.
Frequently Asked Questions:
Q1. What is the growth rate of the Medical Disposable Products market?
The Medical Disposable Products market is projected to expand at a CAGR of 6.65% during the forecast period from 2026 to 2034.
Q2. What is the market size of the Medical Disposable Products market?
The Medical Disposable Products market is estimated at USD 504.5 billion in 2025 and is projected to reach USD 916.7 billion by 2034.
Q3. Which region dominates the Medical Disposable Products market?
North America dominated the Medical Disposable Products market with a 40% share of global revenue in 2025, supported by advanced healthcare infrastructure, high per-capita healthcare spending, a dense concentration of hospitals and ambulatory surgical centers, and stringent FDA regulatory standards. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the Medical Disposable Products market?
The principal drivers are rising global surgical and diagnostic procedure volumes; heightened infection-control standards following the COVID-19 pandemic; the rising global burden of chronic disease and an aging population expanding demand for infusion, blood collection, and wound care products; growth of ambulatory surgical centers and outpatient care; and continued regulatory reinforcement of single-use, sterile-product requirements.
Q5. Who are the major players in the Medical Disposable Products market?
The major players include Becton, Dickinson and Company (BD), Cardinal Health, Medline Industries, Inc., 3M Company, Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, and Molnlycke Health Care AB, among other active providers profiled in the Competitive Landscape section.
Table of Contents
1. Medical Disposable Products Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumptions
2. Medical Disposable Products Market Executive Summary
- 2.1 Market at a Glance
3. Medical Disposable Products Market Key Factors Analysis
- 3.1 Medical Disposable Products Market Drivers
- 3.1.1 Rising Surgical and Diagnostic Procedure Volumes
- 3.1.2 Heightened Infection-Control Standards
- 3.1.3 Expanding Chronic Disease Burden and Aging Population
- 3.1.4 Growth of Ambulatory Surgical Centers and Outpatient Care
- 3.2 Medical Disposable Products Market Restraints and Challenges
- 3.2.1 Environmental Concerns and Plastic Waste Regulation
- 3.2.2 Price Competition and Reimbursement Pressure
- 3.2.3 Raw Material Volatility and Supply Chain Risk
- 3.3 Medical Disposable Products Market Opportunities
- 3.3.1 Sustainable and Biodegradable Material Innovation
- 3.3.2 Emerging-Market Manufacturing and Distribution Expansion
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
- 5.1 United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
6. Medical Disposable Products Market Porter's Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Buyers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
7. Medical Disposable Products Market Assessment
- 7.1 By Product Type
- 7.1.1 Disposable Syringes & Needles
- 7.1.2 IV & Infusion Products
- 7.1.3 Blood Collection & Transfusion Products
- 7.1.4 Disposable Gloves
- 7.1.5 Surgical Masks & Respiratory Disposables
- 7.1.6 Surgical Drapes & Gowns
- 7.1.7 Wound Care & Dressing Products
- 7.1.8 Urinary & Urological Disposables
- 7.1.9 Others
- 7.2 By Material
- 7.2.1 Plastic
- 7.2.2 Rubber & Latex
- 7.2.3 Nonwoven Materials
- 7.2.4 Paper & Paperboard
- 7.2.5 Glass
- 7.2.6 Others
- 7.3 By Sterility
- 7.3.1 Sterile
- 7.3.2 Non-Sterile
- 7.4 By Application
- 7.4.1 Surgical Procedures
- 7.4.2 Infection Control
- 7.4.3 Drug Delivery & Infusion
- 7.4.4 Wound Management
- 7.4.5 Diagnostic & Laboratory Testing
- 7.4.6 Blood Collection & Transfusion
- 7.4.7 Respiratory Care
- 7.4.8 Others
- 7.5 By End-Users
- 7.5.1 Hospitals
- 7.5.2 Ambulatory Surgical Centers
- 7.5.3 Clinics & Physician Offices
- 7.5.4 Diagnostic & Research Laboratories
- 7.5.5 Others
- 7.6 By Geography
- 7.6.1 North America
- 7.6.1.1 United States Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.1.2 Canada Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.1.3 Mexico Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.2 Europe
- 7.6.2.1 Germany Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.2.2 United Kingdom Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.2.3 France Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.2.4 Italy Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.2.5 Spain Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.2.6 Rest of Europe Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.3 Asia-Pacific
- 7.6.3.1 China Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.3.2 Japan Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.3.3 India Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.3.4 Australia Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.3.5 South Korea Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.3.6 Rest of Asia-Pacific Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.4 Rest of World
- 7.6.4.1 Middle East Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.4.2 Africa Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.4.3 South America Medical Disposable Products Market Size in USD million (2023-2034)
- 7.6.1 North America
8. Medical Disposable Products Market Competitive Landscape
- 8.1 Market Concentration and Structure
- 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)
9. Medical Disposable Products Market Startup Funding and Investment Trends
10. Medical Disposable Products Market Company and Product Profiles
- 10.1 Becton, Dickinson and Company (BD)
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Service Portfolio
- 10.1.5 Strategic Initiatives / Entropy
- 10.2 Cardinal Health
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Portfolio
- 10.2.5 Strategic Initiatives / Entropy
- 10.3 Medline Industries, Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Portfolio
- 10.3.5 Strategic Initiatives / Entropy
- 10.4 3M Company
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Portfolio
- 10.4.5 Strategic Initiatives / Entropy
- 10.5 Medtronic plc
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Portfolio
- 10.5.5 Strategic Initiatives / Entropy
- 10.6 Baxter International Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Portfolio
- 10.6.5 Strategic Initiatives / Entropy
- 10.7 B. Braun Melsungen AG
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Portfolio
- 10.7.5 Strategic Initiatives / Entropy
- 10.8 Terumo Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Portfolio
- 10.8.5 Strategic Initiatives / Entropy
- 10.9 Nipro Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Portfolio
- 10.9.5 Strategic Initiatives / Entropy
- 10.10 Molnlycke Health Care AB
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Portfolio
- 10.10.5 Strategic Initiatives / Entropy
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.
